NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
17/06/2025
Voltar para busca
Dado oficial do USPTO
ET HEALTHCARE
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Snapshot rápido
ET HEALTHCARE
ST13
US500000088907220Classe
1, 5, 9, 10
Pedido
88907220
Registro
7836259
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
51
Atualização mais recente
17/06/2025
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
1, 5, 9, 10
Data de depósito
08/05/2020
Data de registro
17/06/2025
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
17/06/2025
Última transação
17/06/2025
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Fundamento do pedido
Intent to use
Primeiro uso
2014-06-00
Primeiro uso no comércio
2014-06-00
Código do desenho
4
Tipo de titular
03
Localização do titular
Palo Alto, CA, KY
Examinador
BURDECKI, ANNA C
Unidade examinadora
L80
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
A. S. (pessoa física)
Representantes
Andrew T. Pettit PERKINS COIE LLP
Classificação técnica
Classes Nice
Classe 1Classe 5Classe 9Classe 10
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 1
Reagents for reacting with biomolecules for scientific use; reagents for scientific use; reagents for reacting with biomolecules for research use; reagents for research use; diagnostic reagents for scientific research use; diagnostic reagentsbufferspreparationsexcept for medical and veterinary use; biochemical reagents used for non-medical purposes for detecting and/or analyzing antigensantibodiesproteinsligandsnucleotides; laboratory chemicalsantibody reagents used for the detection of antigens or antibodies in liquidcelltissue analysis for in vitro diagnostic use; diagnostic preparations other than for medical or veterinary purposesreagentsbufferspreparations for altering the nature of a probe to which biomolecules bind over the course of a diagnostic procedure; diagnostic preparations other than for medical or veterinary purposesreagentsbufferspreparations for modifying a probe to which biomolecules bind for diagnostic purposes
Classe 5
Diagnostic reagents for medical use; diagnostic preparations for medical or veterinary purposesreagentsbufferspreparations for altering the nature of a probe to which biomolecules bind over the course of a diagnostic procedure; diagnostic preparations for medical or veterinary purposesreagentsbufferspreparations for modifying a probe to which biomolecules bind for diagnostic purposes reagentsbufferspreparations for modifying a probe to which biomolecules bind for diagnostic purposes
Classe 9
Optical instruments for measuring a reaction by monitoring changes in the reflection of lightinterferometers; laboratory instruments in the nature of interferometers for use in collecting real-time measurements to support the analysis of biological molecules at different stages of therapeutic development; probes for scientificresearchdiagnostic purposesnot for medical or veterinary purposes; probes for scientific purposesprobes to which biomolecules bind over the course of a scientificresearchdiagnostic procedure; interferometric sensors; probes for scientific purposesprobes to which biomolecules bind during a scientificresearchdiagnostic procedure; probes for label-free analysis of assays being probes for scientific purposes; regenerable probes for scientific purposeprobes for use in multiple scientificresearchdiagnostic procedures; downloadable computer software for scientificresearchdiagnostic analysis of interferometric measurements; downloadable computer software for scientificresearchdiagnostic analysisfor performing antibody titer determination and isotyping; laboratory apparatusimmunoassay analyzers for measuring presence and/or concentration of biomolecules in a sample; laboratory apparatusautomated immunoassay analyzers for scientificresearchdiagnostic usenot for medical purposes
Classe 10
Medical instrumentsdiagnostic instruments for the analysis of body fluids through the measuring of light interference; medical diagnostic instruments for the analysis of body fluids through interferometry; medical diagnostic instruments for the analysis of biomolecules through interferometry; medical diagnostic tool in the nature of medical instruments for analyzing body fluids for investigating scientific questions and conducting tests; interferometers for medical use; interferometric sensors for medical use; probes for detecting and/or analyzing molecules in protein or nucleotide arrays for medical purposes; probes to which biomolecules bind during a medical procedure; probes for medical purposes for label-free analysis of assays; regenerable probes for use in multiple medical procedures; diagnostic kits consisting primarily of antibodies and reagents for use in disease testing for medical purposes; medical diagnostic apparatusimmunoassay analyzers for measuring presence and/or concentration of biomolecules in a sample; medical diagnostic apparatusautomated immunoassay analyzers for medical use
Publicações
Histórico de despachos e eventos da marca no USPTO.
51 publicações encontradas
R.PR
REGISTERED-PRINCIPAL REGISTER
17/06/2025
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
27/05/2025
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
27/05/2025
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
23/04/2025
SUPC
STATEMENT OF USE PROCESSING COMPLETE
22/04/2025
EX4G
SOU EXTENSION 4 GRANTED
22/04/2025
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
17/04/2025
IUAF
USE AMENDMENT FILED
09/01/2025
EXT4
SOU EXTENSION 4 FILED
09/01/2025
EEXT
SOU TEAS EXTENSION RECEIVED
09/01/2025
EISU
TEAS STATEMENT OF USE RECEIVED
09/01/2025
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
03/07/2024
EX3G
SOU EXTENSION 3 GRANTED
03/07/2024
EXT3
SOU EXTENSION 3 FILED
03/07/2024
EEXT
SOU TEAS EXTENSION RECEIVED
03/07/2024
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
12/01/2024
EX2G
SOU EXTENSION 2 GRANTED
10/01/2024
EXT2
SOU EXTENSION 2 FILED
10/01/2024
EEXT
SOU TEAS EXTENSION RECEIVED
10/01/2024
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
12/07/2023
EX1G
SOU EXTENSION 1 GRANTED
10/07/2023
EXT1
SOU EXTENSION 1 FILED
10/07/2023
EEXT
SOU TEAS EXTENSION RECEIVED
10/07/2023
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
10/01/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
15/11/2022
PUBO
PUBLISHED FOR OPPOSITION
15/11/2022
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
26/10/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
13/10/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
12/10/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
11/10/2022
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
11/10/2022
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
23/08/2022
GNFR
FINAL REFUSAL E-MAILED
23/08/2022
CNFR
FINAL REFUSAL WRITTEN
23/08/2022
RCCK
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
29/06/2022
RCCK
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
10/06/2022
RCCK
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
13/05/2022
RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
27/09/2021
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
05/03/2021
GNSL
LETTER OF SUSPENSION E-MAILED
05/03/2021
CNSL
SUSPENSION LETTER WRITTEN
05/03/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
10/02/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
09/02/2021
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
09/02/2021
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
10/08/2020
GNRT
NON-FINAL ACTION E-MAILED
10/08/2020
CNRT
NON-FINAL ACTION WRITTEN
10/08/2020
DOCK
ASSIGNED TO EXAMINER
04/08/2020
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
20/05/2020
NWAP
NEW APPLICATION ENTERED
12/05/2020
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace ET HEALTHCARE ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.